Search

Inpatient rehabilitation application to this patient population is novel, as their potential for meeting developmental milestones has improved with the advent of disease-modifying treatments. Novel treatments have dramatically improved the medical and functional prognosis for patients with SMA. It is also not known how rehabilitation therapy frequency and intensity may influence outcomes, as therapy regimens for the 15 patients were not reported.[4] We present a case of a patient with SMA treated with onasemnogene abeparvovec-xioi who was admitted to inpatient rehabilitation. [Extracted from the article]